About Endo International
Endo International is a company based in Malvern (United States) founded in 1997. The company has 1,431 employees as of September 30, 2024. Endo International has completed 14 acquisitions, including American Medical Systems, Auxilium Pharmaceuticals and BML Pharma. Endo International offers products and services including Sterile Injectables and Generics. Endo International operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Malvern, United States
- Employees 1431 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endo, Inc.
-
Annual Revenue
$2.01 B (USD)-13as on Dec 31, 2023
-
Net Profit
-$2.45 B (USD)16as on Dec 31, 2023
-
EBITDA
-$960.07 M (USD)72as on Dec 31, 2017
-
Latest Funding Round
$170.57 M (USD), Post-IPO
Mar 21, 2024
-
Investors
HHS
& 1 more
-
Employee Count
1431
as on Sep 30, 2024
-
Investments & Acquisitions
American Medical Systems
& 13 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endo International
Endo International offers a comprehensive portfolio of products and services, including Sterile Injectables and Generics.
Products for hospital use in reducing complexity and enhancing patient care
High-quality generic medicines for retail and pharmacy distribution
People of Endo International
Unlock access to complete
Unlock access to complete
Sales and Marketing
45 people
Software Development Team
40 people
Leadership Team
26 people
Product Management Team
15 people
Operations Team
13 people
Human Resources and Administration
9 people
Legal and Compliance
7 people
Senior Team
4 people
Unlock access to complete
Funding Insights of Endo International
Investors in Endo International
Endo International has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Kelso & Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Endo International
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endo International
Endo International has strategically engaged in corporate development activities, having acquired 14 companies. Notable acquisitions include American Medical Systems, Auxilium Pharmaceuticals and BML Pharma.
Investment portfolio details for Endo International
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Energy and telecommunications cable systems are manufactured and distributed internationally.
|
Locked | Locked | 2015 | Locked | |
|
Comprehensive EMR software for urologists is developed and offered.
|
Locked | Locked | 2005 | Locked | |
|
Generic drugs are manufactured and distributed by DAVA Pharmaceuticals.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Endo International
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Endo International
Detailed financials for Endo International
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endo International Comparisons
Peer comparison for Endo International
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endo International
Endo International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Endo International
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endo International
Complete news archive for Endo International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endo International
Endo International was founded in 1997.
Endo International is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
As of Sep 30, 2024, the latest employee count at Endo International is 1,431.
Annual revenue of Endo International is $2.01B as on Dec 31, 2023.
Endo International, backed by 171246909.0 from HHS, Kelso Company, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Endo International's top competitors include Merck, Roivant Sciences and AbbVie.
Endo International offers Sterile Injectables and Generics.
Endo International has made 14 acquisitions, including American Medical Systems, Auxilium Pharmaceuticals, and BML Pharma.
Endo International has 2 investors. Key investors include HHS, and Kelso & Company.